MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2298/sarh1010614s

Медицинская библиотека · Srpski arhiv za celokupno lekarstvo · 2010

[JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation].

Spasovski Vesna, Tosić Natasa, Kostić Tatjana, Pavlović Sonja, Colović Milica

Аннотация на английскомСтатьяПеревод в очереди

Аннотация

INTRODUCTION

An acquired somatic mutation V617F in Janus kinase 2 gene (JAK2) is the cause of uncontrolled proliferation in patients with myeloproliferative neoplasms. It is known that uncontrolled myeloid cell proliferation is also provoked by alteration in other genes, e.g. mutations in receptor tyrosine kinase FLT3 gene. FLT3 represents the most frequently mutated gene in acute myeloid leukaemia. Interestingly, mutated FLT3-ITD (internal tandem duplication) protein is a member of the same signalling pathway as JAK2 protein, the STATS signalling pathway. STAT5 activation is recognized as important for self-renewal of haematopoetic stem cells.

OBJECTIVE

The aim of this study was the detection of JAK2-V617F mutation in patients with myeloproliferative neoplasms. Additionally, we investigated the presence of FLT3-ITD mutation in JAK2-V617F-positive patients in order to shed the light on the hypothesis of a similar role of these two molecular markers in haematological malignancies.

METHODS

Using allele-specific PCR, 61 patients with known or suspected diagnosis of myeloproliferative neoplasms were tested for the presence of JAK2-V617F mutation. Samples that were positive for JAK2 mutation were subsequently tested for the presence of FLT3-ITD mutation by PCR.

RESULTS

Eighteen of 61 analysed patients were positive for JAK2-V617F mutation. Among them, 8/18 samples were diagnosed as polycythaemia vera, and 10/18 as essential thrombocythaemia. None of JAK2-V617F-positive patient was positive for FLT3-ITD mutation.

CONCLUSION

This study suggests that one activating mutation is sufficient for aberrant cell proliferation leading to malignant transformation of haematopoetic stem cell.

Для цитирования: Spasovski Vesna, Tosić Natasa, Kostić Tatjana, Pavlović Sonja, Colović Milica. [JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation].. Srpski arhiv za celokupno lekarstvo. 2010. DOI: 10.2298/sarh1010614s.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.